Cell-penetrating albumin conjugates for enhanced doxorubicin delivery

Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor

(2013) Qi Yin et al.   ADVANCED DRUG DELIVERY REVIEWS

PEGylated denatured bovine serum albumin modified water-soluble inorganic nanocrystals as multifunctional drug delivery platforms

(2013) Liming Zhang et al.   Journal of Materials Chemistry B

TAT-modified nanosilver for combating multidrug-resistant cancer

(2012) Jinhua Liu et al.   BIOMATERIALS

In vivo delivery of cell-permeable antisense hypoxia-inducible factor 1α oligonucleotide to adipose tissue reduces adiposity in obese mice

(2012) Yoon Shin Park et al.   JOURNAL OF CONTROLLED RELEASE

Skin-permeable quaternary nanoparticles with layer-by-layer structure enabling improved gene delivery

(2012) Yongxin Yang et al.   JOURNAL OF MATERIALS CHEMISTRY

Methoxy poly(ethylene glycol) conjugated denatured bovine serum albumin micelles for effective delivery of camptothecin

(2012) Liming Zhang et al.   Polymer Chemistry

Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance

(2011) Alina Shapira et al.   DRUG RESISTANCE UPDATES

Low molecular weight protamine/insulin formulation with potential to attenuate protamine-masqueraded insulin allergy

(2011) Huining He et al.   MACROMOLECULAR RESEARCH

Gold-doxorubicin nanoconjugates for overcoming multidrug resistance

(2011) Yan-Juan Gu et al.   Nanomedicine-Nanotechnology Biology and Medicine

Thermal aggregation of bovine serum albumin studied by asymmetrical flow field-flow fractionation

(2010) Gebrenegus Yohannes et al.   ANALYTICA CHIMICA ACTA

Synthetic Skin-Permeable Proteins Enabling Needleless Immunization

(2010) Yongzhuo Huang et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Specific down regulation of 3T3-L1 adipocyte differentiation by cell-permeable antisense HIF1α-oligonucleotide

(2010) Yoon Shin Park et al.   JOURNAL OF CONTROLLED RELEASE

Anti-Apoptotic Mechanisms of Drug Resistance in Cancer

(2009) T. Wilson et al.   CURRENT CANCER DRUG TARGETS

Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles

(2008) Felix Kratz   JOURNAL OF CONTROLLED RELEASE